Castelion Raises $1 Billion Series C at $13 Billion Valuation to Scale Hypersonic Missile Production
Castelion, a startup based in Torrance, California that builds hypersonic weapon systems, has closed a $1 billion Series C funding round at a $13 billion valuation. The round was co-led by Andreessen Horowitz, Carlyle, and JP Morgan Chase, with existing backers Lightspeed, General Catalyst, and Altimeter also participating (TechCrunch).
The financing splits into $800 million in equity and a $250 million revolving credit facility. Castelion announced the raise on its official newsroom on August 19, stating the capital will accelerate scaled production of its Blackbeard missile platform (Castelion Newsroom). The company will also use the funds to expand its product portfolio to include longer-range strike weapons and defensive systems (Castelion News).
Founded in 2022 by former SpaceX executives, Castelion has secured more than $500 million in U.S. military contracts over the past 18 months. The company describes Blackbeard as its first low-cost, mass-producible hypersonic strike missile, named after the English pirate. Production will take place at its New Mexico facility.
Castelion frames its mission as working to "restore America's conventional deterrence capability" (Castelion News). That framing aligns with a concrete procurement gap: the Pentagon has been seeking to acquire more hypersonic weapons — missiles that travel above Mach 5, or five times the speed of sound — because the U.S. stockpile has not kept pace with China's (TechCrunch).
The round's structure tells its own story about how defense-tech financing has evolved. A $250 million revolving credit facility alongside $800 million in equity signals that lenders are underwriting manufacturing capacity, not just research and development spending. Traditional defense contractors have historically relied on cost-plus contracts — where the government pays a company its costs plus a guaranteed profit margin — and government-funded facility buildouts. Castelion is raising venture and debt capital to build production lines on its own balance sheet, then selling finished systems to the Pentagon. The Carlyle and JP Morgan involvement, in particular, brings institutional credibility from private equity and debt markets that pure venture rounds lack.
The investor composition also bridges two worlds that have not always overlapped. Andreessen Horowitz's co-lead role continues the pattern of Silicon Valley venture firms moving aggressively into defense technology, a sector they largely avoided a decade ago. General Catalyst and Lightspeed's participation as existing backers signals follow-on conviction from growth-stage investors. And Altimeter's presence rounds out a syndicate that spans early-stage venture, growth equity, and now alternative asset management.
Castelion's emphasis on "low-cost" and "mass-producible" in its Blackbeard description is worth examining. The U.S. hypersonic programs that have dominated public discussion, such as the Air-launched Rapid Response Weapon and the Conventional Prompt Strike system, have been criticized for high per-unit costs and limited production volumes. A startup that can deliver Mach 5-plus weapons at meaningfully lower unit economics, and at production cadence rather than small artisanal batch builds, would address a real operational constraint. Whether Castelion can clear that bar at scale is what the Series C capital is now being deployed to prove.
The company's planned expansion into longer-range strike weapons and defensive systems also indicates ambitions beyond a single product line. Hypersonic defensive systems — designed to intercept incoming hypersonic threats — are technically distinct from offensive platforms and, by most accounts, a harder engineering problem. The fact that Castelion is signaling this as a near-term use of capital suggests it has underlying capability it believes transfers across both mission profiles.
The broader context here is the speed of Castelion's trajectory. Founded in 2022, the company has accumulated over $500 million in military contracts in roughly 18 months and reached a $13 billion valuation within four years of incorporation. That pace compresses what has traditionally been a multi-decade defense acquisition timeline. Whether that acceleration is sustainable, or whether it introduces programmatic risk that only manifests at higher production volumes, will be determined by execution against the Series C's stated production targets.
The Pentagon's hypersonic stockpile gap with China provides the demand-side context that makes Castelion's value proposition legible. A startup cannot close a strategic munitions gap on its own, but it can offer the procurement system a faster path from prototype to production than the traditional prime contractor model has delivered. That is the bet the Series C syndicate is making.
